[Federal Register Volume 67, Number 225 (Thursday, November 21, 2002)]
[Notices]
[Pages 70231-70232]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-29546]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, SBIR Phase II: Topic 
70: Detection and Assessment of Urologic and Renal 
Diseases.
    Date: December 6, 2002.
    Time: 3 pm to 4:30 pm.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6707 Democracy Blvd. 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Lakshmanan Sankaran, PhD, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, Room 754, 6707 Democracy 
Boulevard, National Institutes of Health, Bethesda, MD 20892-6600, 
(301) 594-7799, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing

[[Page 70232]]

limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: November 14, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-29546 Filed 11-20-02; 8:45 am]
BILLING CODE 4140-01-M